Quantification of the chemokines CCL17 and CCL22 in human colorectal adenocarcinomas

Molecular Medicine Reports

Volumn 1, Issue 2, 2008, Pages 211-217

  Wågsäter, Dick ^a   Dienus, Olaf ^b   Löfgren, Sture ^b   Hugander, Anders ^b   Dimberg, Jan ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c JÖNKÖPING UNIVERSITY   (Sweden)

Author keywords

CCL17; CCL22; Colorectal cancer; Polymorphism; Protein expression

Indexed keywords

MACROPHAGE DERIVED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; AGED; ARTICLE; CANCER TISSUE; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; FIBROBLAST; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SCREENING; STROMA CELL; UPREGULATION;

EID: 69249141423     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Moser B, Wolf M, Walz A and Loetscher P: Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25: 75-84, 2004. (Pubitemid 38167488)
2. Dwinell MB, Johanesen PA and Smith JM: Immunobiology of epithelial chemokines in the intestinal mucosa. Surgery 133: 601-607, 2003.
3. Luster AD: Chemokines regulate lymphocyte homing to the intestinal mucosa. Gastroenterology 120: 291-294, 2001.
4. Arya M, Patel HR and Williamson M: Chemokines: key players in cancer. Curr Med Res Opin 19: 557-564, 2003.
5. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
6. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
7. Balkwill F: Chemokine biology in cancer. Semin Immunol 15: 49-55, 2003.
8. Strieter RM, Burdick MD, Mestas J, Gomperts BN, Keane MP and Belperio JA: Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 42: 768-778, 2006.
9. Zlotnik A: Chemokines in neoplastic progression. Semin Cancer Biol 14: 181-185, 2004.
10. Ohta M, Tanaka F, Yamaguchi H, Sadanaga N, Inoue H and Mori M: The high expression of Fractalkine results in a better prognosis for colorectal cancer patients. Int J Oncol 26: 41-47, 2005.
11. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E and Kosma VM: Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182: 318-324, 1997. (Pubitemid 27285785)
12. Kanagawa N, Niwa M, Hatanaka Y, Tani Y, Nakagawa S, Fujita T, Yamamoto A and Okada N: CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma. Int J Cancer 121: 2013-2022, 2007. (Pubitemid 47463165)
13. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M and Yoshie O: Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 271: 21514-21521, 1996. (Pubitemid 26293018)
14. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S and Lanzavecchia A: Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28: 2760-2769, 1998. (Pubitemid 28425234)
15. Campell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, Andrew DP, Warnke R, Ruffing N, Kassam N, Wu L and Butcher EC: The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400: 776-780, 1999. (Pubitemid 29399540)
16. Judge F, Alizadeh M, Boissier C, Chantry D, Siproudhis L, Corbinais S, Quelvennec E, Dyard F, Campion JP, Gosselin M, Bretagne JF, Semana G and Heresbach D: Quantitation of chemokine (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis. Eur Cytokine Netw 12: 468-477, 2001. (Pubitemid 32905266)
17. Yu B, Koga T, Urabe K, Moroi Y, Maeda S, Yanagihara Y and Furue M: Differential regulation of thymus- and activation-regulated chemokine induced by IL-4, IL-13, TNF-α and IFN-γ in human keratinocyte and fibroblast. J Dermatol Sci 30: 29-36, 2002. (Pubitemid 35287147)
18. Yoshie O, Imai T and Nomiyama H: Chemokines in immunity. Adv Immunol 78: 57-110, 2001.
19. Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K and Yoshie O: Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11: 81-88, 1999. (Pubitemid 29037591)
20. D'Ambrosio D, Iellem A, Bonecchi R, Mazzeo D, Sozzani S, Mantovani A and Sinigaglia F: Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 161: 5111-5115, 1998. (Pubitemid 28519063)
21. Sallusto F, Lenig D, Mackay CR and Lanzavecchia A: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187: 875-883, 1998. (Pubitemid 28141661)
22. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J and Enk AH: Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripherial blood. J Exp Med 193: 1285-1294, 2001. (Pubitemid 32524778)
23. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD and Lechler RI: Human CD4(+) CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 98: 2736-2744, 2001.
24. Godiska R, Chantry D, Raport CJ, Sozzani S, Allavena P, Leviten D, Mantovani A and Gray PW: Human macrophagederived chemokine (MDC) a novel chemoattractant for monocytes, monocyte-derived dendritic cells and natural cells. J Exp Med 185: 1595-1604, 1997. (Pubitemid 27203256)
25. Berin CM, Dwinell MB, Eckman L and Kagnoff MF: Production of MDC/CCL22 by human intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 280: G1217-G1226, 2001. (Pubitemid 32552425)
26. + T lymphocytes in human colorectal carcinoma. Int J Cancer 116: 949-956, 2005.
27. Fisher SA, Moody A, Mirza MM, Cuthbert AP, Hampe J, Macpherson A, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM and Mathew CG: Genetic variation at the chromosome 16 chemokine gene cluster: development of a strategy for association studies in complex disease. Ann Hum Genet 67: 377-390, 2003. (Pubitemid 37184450)
28. Sekiya T, Tsunami Y, Miyamasu M, Ohta K, Morita A, Saeki H, Matsushima K, Yoshie O, Tsuchiya N, Yamaguchi M, Yamamoto K and Hirai K: Variations in the human Th2-specific chemokine TARC gene. Immunogenetics 54: 742-745, 2003. (Pubitemid 36188540)
29. Tsunemi Y, Komine M, Sekiya T, Saeki H, Nakamura K, Kakinuma T, Kagami S, Fujita H, Asano N, Tanida Y, Wakugawa M, Torii H and Tamaki K: The -431C>T polymorphism of the thymus and activation-regulated chemokine increases the promoter activity but is not associated with susceptibility to atopic dermatitis in Japanese patients. Exp Dermatol 13: 715-719, 2004. (Pubitemid 39481025)
30. Hashimoto S, Nakamura K, Oyama N, Kaneko F, Tsunemi Y, Saeki H and Tamaki K: Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived cells reflects the disease activity in patients with atopic dermatitis. J Dermatol Sci 44: 93-99, 2006. (Pubitemid 44499010)
31. Ferenczi K, Fuhlbrigge RC, Pinkus JL, Pinkus GS and Kupper TS: Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 119: 1404-1410, 2002. (Pubitemid 36005628)
32. + T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163: 5211-5218, 1999.
33. + regulatory T cells in human colorectal cancer. J Transl Med 4: 52, 2006.